Wegovy tablet vs injection: Which weight management treatment is right

If you’re considering Wegovy and deciding between the new daily tablet and the once-weekly injection, both use the same active ingredient: Semaglutide. But while they work in a similar way, the experience and administration of taking them can feel quite different.

For some people, a daily tablet will be an obvious choice. For others, the injection may be simpler. This article compares the two from a practical standpoint to help you decide which may suit you.

Explore our range of weight loss injections and weight loss tablets. Get £15 off your first weight loss order with code: START15.

In this article:

• What’s the difference between Wegovy tablets and injections?

• Which is easier to take day to day?

• How do the dosing schedules compare?

• Is the Wegovy tablet as effective as the injection?

• What about side effects?

• Which might be right for you?

• Can you switch between Wegovy tablets and injections?

What’s the difference between Wegovy tablets and injections?

The main difference is how you take them:

• The Wegovy injection is given once weekly under the skin using a pre-filled pen. Depending on your dose, this may be a multi-dose FlexTouch pen, where you attach a new needle for each injection, or a single-use prefilled pen for the newer 7.2mg strength, used once and then safely disposed of (1-2).

• The Wegovy tablet is taken once daily by mouth. Semaglutide is harder for the body to absorb when swallowed. Because of this, the tablet has strict timing instructions. It needs to be taken first thing in the morning on an empty stomach with a small amount of water only, and then wait 30 minutes before eating or drinking or taking any other medications (3).

Here is a closer look at the differences at a glance:

*Wegovy injections are usually stored in the fridge before first use. Once opened, FlexTouch pens can be kept below 30°C for up to 6 weeks, while the 7.2mg single-use pen can be kept unrefrigerated for up to 28 days.

Which is easier to take day to day?

Whether you find Wegovy tablets or injections easier to take depends entirely on your lifestyle.

At first glance, a weight management tablet may seem easier, as there are no needles, sharps bins, or injection techniques to learn. But the Wegovy tablet comes with stricter instructions that need to be followed for the medicine to work fully, which may make it inconvenient if:

Your mornings are unpredictable

You have young children

You work shifts

You travel frequently across time zones

You already take morning medications

You struggle with remembering daily treatment

For some people, a once-weekly injection for weight loss that can be taken on a more flexible schedule is less disruptive. That said, injections may require more planning around storage and travel, whereas tablets are generally simpler to carry and store

How do the dosing schedules compare?

Wegovy injections and tablets are both introduced gradually to help your body adjust and reduce the risk of side effects like nausea, vomiting, diarrhoea, and constipation.

Although the tablet contains higher milligram doses, this does not mean it is stronger. Because oral semaglutide is absorbed less efficiently, larger doses are needed to achieve a similar effect, but both reach these broadly comparable maintenance treatment levels through slightly different pathways.

The main difference is the number of steps:

• The Wegovy tablet usually increases across four dose levels (3): 1.5mg → 4mg → 9mg → 25mg

• The standard Wegovy injection reaches its maintenance dose in five steps (3): 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg

For both oral and injectable semaglutide, each step lasts around four weeks, although you may stay on a lower dose for longer if you struggle with side effects.

For people who need extra support after plateauing on standard treatment, a newer 7.2mg Wegovy injection may be considered. There is currently no equivalent higher-dose Wegovy tablet.

Explore our range of weight loss injections and weight loss tablets. Get 10% off your first order.

Is the Wegovy tablet as effective as the injection?

For many patients, yes. But it depends on what you’re comparing.

At its highest dose, the Wegovy tablet appears to be broadly comparable to the standard 2.4mg Wegovy injection, which is the most commonly used maintenance dose. In clinical trials:

• People taking oral semaglutide (the Wegovy tablet) lost an average of 15 to 17% of their starting body weight over 64 weeks (4).

• People taking the standard 2.4mg maintenance dose of injectable Wegovy lost an average of 15% of their starting weight over 68 weeks (5).

But injections offer a higher treatment ceiling. The 7.2mg Wegovy injection has shown an average weight loss of approximately 19% in trials, which may offer an additional step for certain people who have plateaued on standard treatments (6).

It’s also important to remember that trial averages don’t predict your real-world response. Some people exceed these results, while others lose less. This is influenced by dose tolerance, consistency with treatment, lifestyle changes, and individual differences in how your body responds.

What about side effects?

Because both treatments contain semaglutide, the side effects are similar. The most common are digestive symptoms such as nausea, diarrhoea, constipation, and vomiting, with around 70% of people experiencing at least one digestive symptom (5,7). However, in clinical trials:

• The Wegovy tablet appears to cause slightly more nausea and vomiting (4-5)

• The Wegovy injection showed slightly higher rates of constipation and diarrhoea (4-5)

Most side effects were mild to moderate, worst when starting treatment or increasing doses, and improved over time. Some people did stop treatment because of side effects. In trials, this happened in around 7% of people using the tablet and 4% of people on injections (4-5).

One difference unique to injections is the possibility of injection-site reactions, such as redness, itching, bruising, or mild irritation where the pen is used. These are usually mild, but for some people, they can be enough to make a tablet feel more appealing.

Which might be right for you?

When choosing between the Wegovy tablet or injections, there isn’t a single “best” option. The right choice depends on your lifestyle, preferences, and what you’re most likely to stick with.

The Wegovy tablet may suit you if you:

• Dislike injections or have a needle phobia

• Feel more comfortable taking tablets over injectable medicines

• Want to avoid handling needles or sharps disposal

• Travel frequently or want medicines that don’t need to be refrigerated

• Already manage a reliable morning medication routine

• Have experienced injection site irritation with other treatments

Injections may be a better fit if you:

• Prefer less frequent weekly treatment over a daily pill

• Have unpredictable mornings that can make the tablet’s strict timing requirements difficult

• Want a more flexible option with fewer rules around meals and timing

• Struggle to remember daily medication

• Want access to higher-dose options if needed

• Don’t mind injections and prefer a “set it and forget it” approach

Explore our range of weight loss injections and weight loss tablets. Get £15 off your first weight loss order with code: START15.

Can you switch between the two?

Choosing one option now does not necessarily lock you into it. If your lifestyle changes, you struggle with side effects, or the treatment simply doesn’t feel like the right fit, switching may be possible.

Any switch should be guided by a prescriber, who can help decide the safest and most effective way to transition. In general (3):

• Patients already stable on the 2.4mg Wegovy injection may be able to switch directly to the 25mg Wegovy tablet, taking it as their next dose, without restarting the dose escalation process. Switching from tablet to injection requires a one-week gap. You should discuss switching protocols with your prescriber to make sure it is done correctly.

• Patients using lower maintenance doses of injectable Wegovy may need to switch to a lower-strength tablet that provides a similar level of semaglutide exposure, then continue through the usual dose escalation schedule if appropriate.

• If the 25mg tablet does not provide enough weight loss, switching to a higher-dose injectable option such as 7.2mg may be considered if clinically appropriate

However, Wegovy tablets and injections should not be used together. Both contain semaglutide, and combining them would increase the dose beyond what is considered safe.

It is also possible to switch from other weight management injections, such as Mounjaro. You can switch to Wegovy injections or to the tablet, but as you’re moving to a new GLP-1, you’ll usually have to start from a low semaglutide dose and work your way back up through the dosing schedule.

Ready to explore your options?

No matter whether you’re considering Wegovy for the first time, thinking about switching from another treatment, or unsure which format may suit you best, the team at Oxford Online Pharmacy can help you understand your options and what makes sense for your goals and lifestyle.

Explore our range of weight loss injections and weight loss tablets. Get £15 off your first weight loss order with code: START15.

References

1. Wegovy 0.25 mg, FlexTouch solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC) - (emc) [Internet]. medicines.org.uk. 2026.

2. Wegovy 7.2 mg Solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC) - (emc) | 102093 [Internet]. medicines.org.uk. 2026.

3. Novo Nordisk. Wegovy (Semaglutide) prescribing information [Internet]. Plainsboro (NJ): Novo Nordisk; [cited 2026 May 13].

4. Wilding JPH, Batterham RL, Calanna S. Once-Weekly Semaglutide in Adults with Overweight or Obesity. The New England Journal of Medicine [Internet]. 2021 Feb 10;384(11):989–1002.

5. Wharton S, Ildiko Lingvay, Bogdanski P, Duque R, Jacob S, Karlsson T, et al. Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity. New England Journal of Medicine. 2025 Sep 17;393(11):1077–87.

6. Wharton S, Freitas P, Jøran Hjelmesæth, Kabisch M, Kandler K, Ildiko Lingvay, et al. Once-weekly semaglutide 7·2 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial. The Lancet Diabetes & Endocrinology [Internet]. 2025 Sep 1.

7. Wharton S, Calanna S, Davies M, Dicker D, Goldman B, Lingvay I, et al. Gastrointestinal tolerability of once‐weekly Semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss. Diabetes, Obesity and Metabolism. 2021 Oct 4;24(1).